A Plain Language Summary of the Final Analysis of the GRIFFIN Study of Daratumumab Plus Lenalidomide, Bortezomib, and Dexamethasone for People with Newly Diagnosed Multiple Myeloma
Future oncology (London, England)(2024)
Key words
D-RVd,daratumumab,GRIFFIN,lay summary,multiple myeloma,newly diagnosed,plain language summary,transplant eligible
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined